← Back to Search

Poems at diagnosis GROUP for Multiple Myeloma (Microbiome Trial)

N/A
Recruiting
Led By Angela Dispenzieri, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with POEMS syndrome (newly diagnosed or in remission) or with newly diagnosed multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), amyloid light chain (AL) amyloidosis or healthy controls from their households
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Microbiome Trial Summary

A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders

Eligible Conditions
  • Multiple Myeloma

Microbiome Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Microbiome Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gut Microbiome characteristics in patients with POEMS syndrome and other plasma cell disorders

Microbiome Trial Design

6Treatment groups
Experimental Treatment
Group I: Poems in Remission GROUPExperimental Treatment1 Intervention
POEMS in remission (no chemotherapy, radiation, or stem cell transplant for 2 years
Group II: Poems at diagnosis GROUPExperimental Treatment1 Intervention
POEMS at diagnosis (before starting chemotherapy, radiation, or stem cell transplant
Group III: MULTIPLE MYELOMA at diagnosis GROUPExperimental Treatment1 Intervention
Multiple myeloma (before starting chemotherapy, radiation or stem cell transplant
Group IV: MGUS GROUPExperimental Treatment1 Intervention
MGUS -not treated newly diagnosed
Group V: Health controls in same household GROUPExperimental Treatment1 Intervention
household member to be a healthy control (no chemotherapy or gastrointestinal illness to participate)
Group VI: Amyloid at diagnosis GROUPExperimental Treatment1 Intervention
AL amyloidosis (before starting chemotherapy or stem cell transplant)

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,216 Previous Clinical Trials
3,767,248 Total Patients Enrolled
77 Trials studying Multiple Myeloma
9,711 Patients Enrolled for Multiple Myeloma
Angela Dispenzieri, M.D.Principal InvestigatorMayo Clinic in Rochester
4 Previous Clinical Trials
109 Total Patients Enrolled
1 Trials studying Multiple Myeloma
39 Patients Enrolled for Multiple Myeloma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
2021. "Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06252948.
All > Paid Studies Minneapolis
~159 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top